United States Regenerative Medicines Industry 2015 Deep Market Research Report

United States Regenerative Medicines Industry 2015 Deep Market Research Report

Category : Pharmaceuticals
Published On : December  2015
Pages : 120



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
The United States Regenerative Medicines Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Regenerative Medicines industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Regenerative Medicines market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Regenerative Medicines industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 149 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Regenerative Medicines
1.2 Classification of Regenerative Medicines
1.3 Applications of Regenerative Medicines
1.4 Industry Chain Structure of Regenerative Medicines
1.5 Industry Overview of Regenerative Medicines
1.6 Industry Policy Analysis of Regenerative Medicines
1.7 Industry News Analysis of Regenerative Medicines

2 Manufacturing Cost Structure Analysis of Regenerative Medicines
2.1 Bill of Materials (BOM) of Regenerative Medicines
2.2 BOM Price Analysis of Regenerative Medicines
2.3 Labor Cost Analysis of Regenerative Medicines
2.4 Depreciation Cost Analysis of Regenerative Medicines
2.5 Manufacturing Cost Structure Analysis of Regenerative Medicines
2.6 Manufacturing Process Analysis of Regenerative Medicines
2.7 China Price, Cost and Gross of Regenerative Medicines 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Regenerative Medicines Manufacturers in 2014
3.3 R&D Status and Technology Source of United States Regenerative Medicines Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Regenerative Medicines Key Manufacturers in 2014

4 Production Analysis of Regenerative Medicines by Regions, Type, and Applications
4.1 United States Production of Regenerative Medicines by Regions 2010-2015
4.2 United States Production of Regenerative Medicines by Type 2010-2015
4.3 United States Sales of Regenerative Medicines by Applications 2010-2015
4.4 Price Analysis of United States Regenerative Medicines Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Regenerative Medicines 2010-2015

5 Consumption Volume and Consumption Value Analysis of Regenerative Medicines by Regions
5.1 United States Consumption Volume of Regenerative Medicines by Regions 2010-2015
5.2 United States Consumption Value of Regenerative Medicines by Regions 2010-2015
5.3 United States Consumption Price Analysis of Regenerative Medicines by Regions 2010-2015

6 Analysis of Regenerative Medicines Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Regenerative Medicines 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Regenerative Medicines 2014-2015
6.3 Sales Overview of Regenerative Medicines 2010-2015
6.4 Supply, Consumption and Gap of Regenerative Medicines 2010-2015
6.5 Import, Export and Consumption of Regenerative Medicines 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Regenerative Medicines 2010-2015

7 Analysis of Regenerative Medicines Industry Key Manufacturers
7.1 Shire Pharmaceuticals
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Shire Pharmaceuticals SWOT Analysis

7.2 Ocata Therapeutics
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Ocata Therapeutics SWOT Analysis

7.3 Genzyme
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Genzyme SWOT Analysis

7.4 Athersys
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Athersys SWOT Analysis

7.5 Kinetic Concepts
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Kinetic Concepts SWOT Analysis

7.6 NuVasive
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 NuVasive SWOT Analysis

7.7 StemCells
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 StemCells SWOT Analysis

7.8 Cytori Therapeutics
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Cytori Therapeutics SWOT Analysis

7.9 Cytomedix
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Cytomedix SWOT Analysis

7.10 Mesoblast
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Mesoblast SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Regenerative Medicines Product Types
8.5 Market Share Analysis of Different Regenerative Medicines Price Levels
8.6 Gross Margin Analysis of Different Regenerative Medicines Applications

9 Marketing Trader or Distributor Analysis of Regenerative Medicines
9.1 Marketing Channels Status of Regenerative Medicines
9.2 Traders or Distributors of Regenerative Medicines with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Regenerative Medicines
9.4 United States Import, Export and Trade Analysis of Regenerative Medicines

10 Development Trend of Regenerative Medicines Industry 2016-2021
10.1 Capacity and Production Overview of Regenerative Medicines 2016-2021
10.2 Production Market Share by Product Types of Regenerative Medicines 2016-2021
10.3 Sales and Sales Revenue Overview of Regenerative Medicines 2016-2021
10.4 United States Sales of Regenerative Medicines by Applications 2016-2021
10.5 Import, Export and Consumption of Regenerative Medicines 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Regenerative Medicines 2016-2021

11 Industry Chain Suppliers of Regenerative Medicines with Contact Information
11.1 Major Raw Materials Suppliers of Regenerative Medicines with Contact Information
11.2 Manufacturing Equipment Suppliers of Regenerative Medicines with Contact Information
11.3 Major Players of Regenerative Medicines with Contact Information
11.4 Key Consumers of Regenerative Medicines with Contact Information
11.5 Supply Chain Relationship Analysis of Regenerative Medicines

12 New Project Investment Feasibility Analysis of Regenerative Medicines
12.1 New Project SWOT Analysis of Regenerative Medicines
12.2 New Project Investment Feasibility Analysis of Regenerative Medicines

13 Conclusion of the United States Regenerative Medicines Industry 2015 Deep Market Research Report


List of Tables and Figures

Figure Picture of Regenerative Medicines
Table Product Specifications of Regenerative Medicines
Table Classification of Regenerative Medicines
Figure United States Sales Market Share of Regenerative Medicines by Product Types in 2014
Table Applications of Regenerative Medicines
Figure United States Sales Market Share of Regenerative Medicines by Applications in 2014
Figure Industry Chain Structure of Regenerative Medicines
Table United States Industry Overview of Regenerative Medicines
Table Industry Policy of Regenerative Medicines
Table Industry News List of Regenerative Medicines
Table Bill of Materials (BOM) of Regenerative Medicines
Table Bill of Materials (BOM) Price of Regenerative Medicines
Table Labor Cost of Regenerative Medicines
Table Depreciation Cost of Regenerative Medicines
Table Manufacturing Cost Structure Analysis of Regenerative Medicines in 2014
Figure Manufacturing Process Analysis of Regenerative Medicines
Table United States Price Analysis of Regenerative Medicines 2010-2015 (USD/Unit)
Table United States Cost Analysis of Regenerative Medicines 2010-2015 (USD/Unit)
Table United States Gross Analysis of Regenerative Medicines 2010-2015
Table Capacity (K Units) and Commercial Production Date of United States Regenerative Medicines Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Regenerative Medicines Manufacturers in 2014
Table R&D Status and Technology Source of United States Regenerative Medicines Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Regenerative Medicines Key Manufacturers in 2014
Table United States Production of Regenerative Medicines by Regions 2010-2015 (K Units)
Table United States Production Market Share of Regenerative Medicines by Regions 2010-2015
Figure United States Production Market Share of Regenerative Medicines by Regions in 2014
Figure United States Production Market Share of Regenerative Medicines by Regions in 2015
Table United States Production of Regenerative Medicines by Types in 2010-2015 (K Units)
Table United States Production Market Share of Regenerative Medicines by Type in 2010-2015
Figure United States Production Market Share of Regenerative Medicines by Type in 2014
Figure United States Production Market Share of Regenerative Medicines by Type in 2015
Table United States Sales of Regenerative Medicines by Applications 2010-2015 (K Units)
Table United States Production Market Share of Regenerative Medicines by Applications 2010-2015
Figure United States Production Market Share of Regenerative Medicines by Applications in 2014
Figure United States Production Market Share of Regenerative Medicines by Applications in 2015
Table Price Comparison of United States Regenerative Medicines Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Regenerative Medicines 2010-2015
Table United States Consumption Volume of Regenerative Medicines by Regions 2010-2015 (K Units)
Table United States Consumption Volume Market Share of Regenerative Medicines by Regions 2010-2015
Figure United States Consumption Volume Market Share of Regenerative Medicines by Regions in 2014
Figure United States Consumption Volume Market Share of Regenerative Medicines by Regions in 2015
Table United States Consumption Value of Regenerative Medicines by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Regenerative Medicines by Regions 2010-2015
Figure United States Consumption Value Market Share of Regenerative Medicines by Regions in 2014
Figure United States Consumption Value Market Share of Regenerative Medicines by Regions in 2015
Table Consumption Price of Regenerative Medicines by Regions 2010-2015 (USD/Unit)
Table United States and Major Manufacturers Capacity of Regenerative Medicines 2010-2015 (K Units)
Table United States Capacity Market Share of Major Regenerative Medicines Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Regenerative Medicines 2010-2015 (K Units)
Table United States Production Market Share of Major Regenerative Medicines Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Regenerative Medicines 2010-2015 (K Units)
Table United States Sales Market Share of Major Regenerative Medicines Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Regenerative Medicines 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Regenerative Medicines Manufacturers 2010-2015
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Regenerative Medicines 2010-2015
Figure United States Capacity Utilization Rate of Regenerative Medicines 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Regenerative Medicines 2010-2015
Figure United States Production Market Share of Major Regenerative Medicines Manufacturers in 2014
Figure United States Production Market Share of Major Regenerative Medicines Manufacturers in 2015
Figure United States Sales Market Share of Major Regenerative Medicines Manufacturers in 2014
Figure United States Sales Market Share of Major Regenerative Medicines Manufacturers in 2015
Figure United States Sales (K Units) and Growth Rate of Regenerative Medicines 2010-2015
Table United States Supply, Consumption and Gap of Regenerative Medicines 2010-2015 (K Units)
Table United States Import, Export and Consumption of Regenerative Medicines 2010-2015 (K Units)
Table Price of United States Regenerative Medicines Major Manufacturers 2010-2015 (USD/Unit)
Table Gross Margin of United States Regenerative Medicines Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Regenerative Medicines 2010-2015 (M USD)
Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Regenerative Medicines 2010-2015
Table Shire Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Shire Pharmaceuticals
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Shire Pharmaceuticals 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Shire Pharmaceuticals 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Shire Pharmaceuticals 2010-2015
Table Shire Pharmaceuticals Regenerative Medicines SWOT Analysis
Table Ocata Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Ocata Therapeutics
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ocata Therapeutics 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Ocata Therapeutics 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Ocata Therapeutics 2010-2015
Table Ocata Therapeutics Regenerative Medicines SWOT Analysis
Table Genzyme Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Genzyme
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genzyme 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Genzyme 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Genzyme 2010-2015
Table Genzyme Regenerative Medicines SWOT Analysis
Table Athersys Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Athersys
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Athersys 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Athersys 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Athersys 2010-2015
Table Athersys Regenerative Medicines SWOT Analysis
Table Kinetic Concepts Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Kinetic Concepts
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Kinetic Concepts 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Kinetic Concepts 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Kinetic Concepts 2010-2015
Table Kinetic Concepts Regenerative Medicines SWOT Analysis
Table NuVasive Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of NuVasive
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of NuVasive 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of NuVasive 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of NuVasive 2010-2015
Table NuVasive Regenerative Medicines SWOT Analysis
Table StemCells Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of StemCells
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of StemCells 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of StemCells 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of StemCells 2010-2015
Table StemCells Regenerative Medicines SWOT Analysis
Table Cytori Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Cytori Therapeutics
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cytori Therapeutics 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Cytori Therapeutics 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Cytori Therapeutics 2010-2015
Table Cytori Therapeutics Regenerative Medicines SWOT Analysis
Table Cytomedix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Cytomedix
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cytomedix 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Cytomedix 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Cytomedix 2010-2015
Table Cytomedix Regenerative Medicines SWOT Analysis
Table Mesoblast Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Regenerative Medicines Picture and Specifications of Mesoblast
Table Regenerative Medicines Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mesoblast 2010-2015
Figure Regenerative Medicines Capacity (K Units), Production (K Units) and Growth Rate of Mesoblast 2010-2015
Figure Regenerative Medicines Production (K Units) and United States Market Share of Mesoblast 2010-2015
Table Mesoblast Regenerative Medicines SWOT Analysis
Table Regenerative Medicines Price by Regions 2010-2015
Table Regenerative Medicines Price by Product Types 2010-2015
Table Regenerative Medicines Price by Companies 2010-2015
Table Regenerative Medicines Gross Margin by Companies 2010-2015
Table Price Comparison of Regenerative Medicines by Regions 2010-2015 (USD/Unit)
Table Price of Different Regenerative Medicines Product Types (USD/Unit)
Table Market Share of Different Regenerative Medicines Price Level
Table Gross Margin of Different Regenerative Medicines Applications
Table Marketing Channels Status of Regenerative Medicines
Table Traders or Distributors of Regenerative Medicines with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Regenerative Medicines (USD/Unit) in 2015
Table United States Import, Export, and Trade of Regenerative Medicines (K Units)
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Regenerative Medicines 2016-2021
Figure United States Capacity Utilization Rate of Regenerative Medicines 2016-2021
Table United States Regenerative Medicines Production by Type 2016-2021 (K Units)
Table United States Regenerative Medicines Production Market Share by Type 2016-2021
Figure United States Production Market Share of Regenerative Medicines by Type in 2021
Figure United States Sales (K Units) and Growth Rate of Regenerative Medicines 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Regenerative Medicines 2016-2021
Figure United States Sales of Regenerative Medicines by Applications 2016-2021 (K Units)
Table United States Production Market Share of Regenerative Medicines by Applications 2016-2021
Figure United States Production Market Share of Regenerative Medicines by Applications in 2021
Table United States Production, Import, Export and Consumption of Regenerative Medicines 2016-2021 (K Units)
Table United States Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Regenerative Medicines 2016-2021
Table Major Raw Materials Suppliers of Regenerative Medicines with Contact Information
Table Manufacturing Equipment Suppliers of Regenerative Medicines with Contact Information
Table Major Players of Regenerative Medicines with Contact Information
Table Key Consumers of Regenerative Medicines with Contact Information
Table Supply Chain Relationship Analysis of Regenerative Medicines
Table New Project SWOT Analysis of Regenerative Medicines
Table New Project Investment Feasibility Analysis of Regenerative Medicines
Table Part of Interviewees Record List

Enquiry Before Buy